BRUNSWICK CORP (BC) Fundamental Analysis & Valuation

NYSE:BC • US1170431092

Current stock price

71.26 USD
+2.35 (+3.41%)
At close:
71.26 USD
0 (0%)
Pre-Market:

This BC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BC Profitability Analysis

1.1 Basic Checks

  • BC had positive earnings in the past year.
  • In the past year BC had a positive cash flow from operations.
  • Of the past 5 years BC 4 years were profitable.
  • Each year in the past 5 years BC had a positive operating cash flow.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • With a Return On Assets value of -2.58%, BC perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
  • BC has a Return On Equity of -8.45%. This is comparable to the rest of the industry: BC outperforms 43.75% of its industry peers.
  • BC's Return On Invested Capital of 5.91% is fine compared to the rest of the industry. BC outperforms 62.50% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BC is in line with the industry average of 7.40%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • With a decent Operating Margin value of 5.83%, BC is doing good in the industry, outperforming 68.75% of the companies in the same industry.
  • BC's Operating Margin has declined in the last couple of years.
  • The Gross Margin of BC (24.84%) is worse than 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of BC has declined.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

3

2. BC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BC is destroying value.
  • Compared to 1 year ago, BC has less shares outstanding
  • BC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BC has been reduced compared to a year ago.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 2.99 indicates that BC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.99, BC perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
  • BC has a debt to FCF ratio of 5.30. This is a neutral value as BC would need 5.30 years to pay back of all of its debts.
  • BC has a Debt to FCF ratio (5.30) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.11 is on the high side and indicates that BC has dependencies on debt financing.
  • The Debt to Equity ratio of BC (1.11) is worse than 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z 2.99
ROIC/WACC0.67
WACC8.81%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BC has a Current Ratio of 1.44. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
  • BC has a Current ratio of 1.44. This is in the lower half of the industry: BC underperforms 68.75% of its industry peers.
  • BC has a Quick Ratio of 1.44. This is a bad value and indicates that BC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BC's Quick ratio of 0.61 is on the low side compared to the rest of the industry. BC is outperformed by 71.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BC Growth Analysis

3.1 Past

  • The earnings per share for BC have decreased strongly by -28.29% in the last year.
  • Measured over the past years, BC shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.40% on average per year.
  • Looking at the last year, BC shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.86% on average over the next years. This is a very strong growth
  • BC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.76% yearly.
EPS Next Y33.56%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue Next Year9.03%
Revenue Next 2Y7.05%
Revenue Next 3Y6.73%
Revenue Next 5Y5.76%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

6

4. BC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.79, BC is valued on the expensive side.
  • BC's Price/Earnings ratio is a bit cheaper when compared to the industry. BC is cheaper than 68.75% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of BC to the average of the S&P500 Index (25.96), we can say BC is valued inline with the index average.
  • The Price/Forward Earnings ratio is 16.32, which indicates a correct valuation of BC.
  • BC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BC is cheaper than 71.88% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.04. BC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.79
Fwd PE 16.32
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 65.63% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BC is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.66
EV/EBITDA 10.69
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BC's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y28.22%
EPS Next 3Y27.67%

6

5. BC Dividend Analysis

5.1 Amount

  • BC has a Yearly Dividend Yield of 2.55%.
  • BC's Dividend Yield is a higher than the industry average which is at 1.27.
  • BC's Dividend Yield is a higher than the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 2.55%

5.2 History

  • On average, the dividend of BC grows each year by 11.59%, which is quite nice.
  • BC has paid a dividend for at least 10 years, which is a reliable track record.
  • BC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.59%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • BC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-82.01%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

BC Fundamentals: All Metrics, Ratios and Statistics

BRUNSWICK CORP

NYSE:BC (3/16/2026, 8:09:05 PM)

Premarket: 71.26 0 (0%)

71.26

+2.35 (+3.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners104.78%
Inst Owner Change-6.26%
Ins Owners0.93%
Ins Owner Change0.11%
Market Cap4.62B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts76.43
Price Target90.25 (26.65%)
Short Float %5.89%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 2.55%
Yearly Dividend1.72
Dividend Growth(5Y)11.59%
DP-82.01%
Div Incr Years12
Div Non Decr Years16
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)0.4%
PT rev (3m)18.85%
EPS NQ rev (1m)-5.48%
EPS NQ rev (3m)-41.06%
EPS NY rev (1m)0.33%
EPS NY rev (3m)2.81%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)3.5%
Valuation
Industry RankSector Rank
PE 21.79
Fwd PE 16.32
P/S 0.86
P/FCF 11.66
P/OCF 8.22
P/B 2.84
P/tB 51.58
EV/EBITDA 10.69
EPS(TTM)3.27
EY4.59%
EPS(NY)4.37
Fwd EY6.13%
FCF(TTM)6.11
FCFY8.58%
OCF(TTM)8.67
OCFY12.16%
SpS82.7
BVpS25.07
TBVpS1.38
PEG (NY)0.65
PEG (5Y)N/A
Graham Number42.95
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 2.72
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z 2.99
F-Score5
WACC8.81%
ROIC/WACC0.67
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y33.56%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year9.03%
Revenue Next 2Y7.05%
Revenue Next 3Y6.73%
Revenue Next 5Y5.76%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year84.19%
EBIT Next 3Y32.29%
EBIT Next 5Y23.77%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC Fundamental Analysis FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 6 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


How profitable is BRUNSWICK CORP (BC) stock?

BRUNSWICK CORP (BC) has a profitability rating of 4 / 10.


What is the valuation of BRUNSWICK CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRUNSWICK CORP (BC) is 21.79 and the Price/Book (PB) ratio is 2.84.


What is the financial health of BRUNSWICK CORP (BC) stock?

The financial health rating of BRUNSWICK CORP (BC) is 3 / 10.